Triple Positive Antiphospholipid Antibody Syndrome in Pregnancy with High Frequency Plasma Exchange: A Case Report
IntroductionTriple antibody positive antiphospholipid syndrome during pregnancy carries a poor prognosis. The placental vasculature is particularly vulnerable to these antibodies resulting in a marked increased risk of fetal growth restriction, placental infarction, abruption, stillbirth, and preter...
Gespeichert in:
Veröffentlicht in: | Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2023, Vol.50 (2), p.154-158 |
---|---|
Hauptverfasser: | , , , |
Format: | Report |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 158 |
---|---|
container_issue | 2 |
container_start_page | 154 |
container_title | Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie |
container_volume | 50 |
creator | Cottrell, Jesse Al Sanani, Ahlim Ogu, Iheanyichukwu Chaffin, David |
description | IntroductionTriple antibody positive antiphospholipid syndrome during pregnancy carries a poor prognosis. The placental vasculature is particularly vulnerable to these antibodies resulting in a marked increased risk of fetal growth restriction, placental infarction, abruption, stillbirth, and preterm severe preeclampsia. Case PresentationWe report a case of a primigravida with triple antibody positive antiphospholipid syndrome that demonstrated placental insufficiency and fetal compromise at a previable gestation. The patient underwent plasma exchange every 48 h for 11 weeks resulting in delivery of a viable infant. Placental blood flow was improved after complete absence of end-diastolic flow in the fetal umbilical artery. ConclusionScheduled plasmapheresis every 48 h can be considered in select cases of antiphospholipid antibody syndrome. |
doi_str_mv | 10.1159/000526349 |
format | Report |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2802423744</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2802423744</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_28024237443</originalsourceid><addsrcrecordid>eNqVjs1OwzAQhH0AifJz4A322EvBsdO04VZVrXqM2t4rkyzJIsd2vS6QtycgXoDDaKRPn0YjxGMmn7JsXj5LKeeq0Hl5JSZZUciZXpTFjbhlfpdS5UutJiIeIwWLUHmmRB8IK5codJ7HWArU_IJX3wxwGFwTfY9ADqqIrTOuHuCTUgc7ajvYRjxf8IdV1nBvYPNVd8a1-AIrWBtG2GPwMd2L6zdjGR_--k5Mt5vjejcL0Y8DnE49cY3WGof-wie1HM8qvchz_Q_1G55nUj8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2802423744</pqid></control><display><type>report</type><title>Triple Positive Antiphospholipid Antibody Syndrome in Pregnancy with High Frequency Plasma Exchange: A Case Report</title><source>DOAJ Directory of Open Access Journals</source><source>Karger Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Cottrell, Jesse ; Al Sanani, Ahlim ; Ogu, Iheanyichukwu ; Chaffin, David</creator><creatorcontrib>Cottrell, Jesse ; Al Sanani, Ahlim ; Ogu, Iheanyichukwu ; Chaffin, David</creatorcontrib><description>IntroductionTriple antibody positive antiphospholipid syndrome during pregnancy carries a poor prognosis. The placental vasculature is particularly vulnerable to these antibodies resulting in a marked increased risk of fetal growth restriction, placental infarction, abruption, stillbirth, and preterm severe preeclampsia. Case PresentationWe report a case of a primigravida with triple antibody positive antiphospholipid syndrome that demonstrated placental insufficiency and fetal compromise at a previable gestation. The patient underwent plasma exchange every 48 h for 11 weeks resulting in delivery of a viable infant. Placental blood flow was improved after complete absence of end-diastolic flow in the fetal umbilical artery. ConclusionScheduled plasmapheresis every 48 h can be considered in select cases of antiphospholipid antibody syndrome.</description><identifier>ISSN: 1660-3796</identifier><identifier>DOI: 10.1159/000526349</identifier><language>eng</language><ispartof>Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 2023, Vol.50 (2), p.154-158</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784,864,4489,27924</link.rule.ids></links><search><creatorcontrib>Cottrell, Jesse</creatorcontrib><creatorcontrib>Al Sanani, Ahlim</creatorcontrib><creatorcontrib>Ogu, Iheanyichukwu</creatorcontrib><creatorcontrib>Chaffin, David</creatorcontrib><title>Triple Positive Antiphospholipid Antibody Syndrome in Pregnancy with High Frequency Plasma Exchange: A Case Report</title><title>Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie</title><description>IntroductionTriple antibody positive antiphospholipid syndrome during pregnancy carries a poor prognosis. The placental vasculature is particularly vulnerable to these antibodies resulting in a marked increased risk of fetal growth restriction, placental infarction, abruption, stillbirth, and preterm severe preeclampsia. Case PresentationWe report a case of a primigravida with triple antibody positive antiphospholipid syndrome that demonstrated placental insufficiency and fetal compromise at a previable gestation. The patient underwent plasma exchange every 48 h for 11 weeks resulting in delivery of a viable infant. Placental blood flow was improved after complete absence of end-diastolic flow in the fetal umbilical artery. ConclusionScheduled plasmapheresis every 48 h can be considered in select cases of antiphospholipid antibody syndrome.</description><issn>1660-3796</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2023</creationdate><recordtype>report</recordtype><recordid>eNqVjs1OwzAQhH0AifJz4A322EvBsdO04VZVrXqM2t4rkyzJIsd2vS6QtycgXoDDaKRPn0YjxGMmn7JsXj5LKeeq0Hl5JSZZUciZXpTFjbhlfpdS5UutJiIeIwWLUHmmRB8IK5codJ7HWArU_IJX3wxwGFwTfY9ADqqIrTOuHuCTUgc7ajvYRjxf8IdV1nBvYPNVd8a1-AIrWBtG2GPwMd2L6zdjGR_--k5Mt5vjejcL0Y8DnE49cY3WGof-wie1HM8qvchz_Q_1G55nUj8</recordid><startdate>20230401</startdate><enddate>20230401</enddate><creator>Cottrell, Jesse</creator><creator>Al Sanani, Ahlim</creator><creator>Ogu, Iheanyichukwu</creator><creator>Chaffin, David</creator><scope>7X8</scope></search><sort><creationdate>20230401</creationdate><title>Triple Positive Antiphospholipid Antibody Syndrome in Pregnancy with High Frequency Plasma Exchange: A Case Report</title><author>Cottrell, Jesse ; Al Sanani, Ahlim ; Ogu, Iheanyichukwu ; Chaffin, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_28024237443</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Cottrell, Jesse</creatorcontrib><creatorcontrib>Al Sanani, Ahlim</creatorcontrib><creatorcontrib>Ogu, Iheanyichukwu</creatorcontrib><creatorcontrib>Chaffin, David</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cottrell, Jesse</au><au>Al Sanani, Ahlim</au><au>Ogu, Iheanyichukwu</au><au>Chaffin, David</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Triple Positive Antiphospholipid Antibody Syndrome in Pregnancy with High Frequency Plasma Exchange: A Case Report</atitle><jtitle>Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie</jtitle><date>2023-04-01</date><risdate>2023</risdate><volume>50</volume><issue>2</issue><spage>154</spage><epage>158</epage><pages>154-158</pages><issn>1660-3796</issn><abstract>IntroductionTriple antibody positive antiphospholipid syndrome during pregnancy carries a poor prognosis. The placental vasculature is particularly vulnerable to these antibodies resulting in a marked increased risk of fetal growth restriction, placental infarction, abruption, stillbirth, and preterm severe preeclampsia. Case PresentationWe report a case of a primigravida with triple antibody positive antiphospholipid syndrome that demonstrated placental insufficiency and fetal compromise at a previable gestation. The patient underwent plasma exchange every 48 h for 11 weeks resulting in delivery of a viable infant. Placental blood flow was improved after complete absence of end-diastolic flow in the fetal umbilical artery. ConclusionScheduled plasmapheresis every 48 h can be considered in select cases of antiphospholipid antibody syndrome.</abstract><doi>10.1159/000526349</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1660-3796 |
ispartof | Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 2023, Vol.50 (2), p.154-158 |
issn | 1660-3796 |
language | eng |
recordid | cdi_proquest_miscellaneous_2802423744 |
source | DOAJ Directory of Open Access Journals; Karger Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
title | Triple Positive Antiphospholipid Antibody Syndrome in Pregnancy with High Frequency Plasma Exchange: A Case Report |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T14%3A28%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Triple%20Positive%20Antiphospholipid%20Antibody%20Syndrome%20in%20Pregnancy%20with%20High%20Frequency%20Plasma%20Exchange:%20A%20Case%20Report&rft.jtitle=Transfusion%20medicine%20and%20hemotherapy%20:%20offizielles%20Organ%20der%20Deutschen%20Gesellschaft%20fur%20Transfusionsmedizin%20und%20Immunhamatologie&rft.au=Cottrell,%20Jesse&rft.date=2023-04-01&rft.volume=50&rft.issue=2&rft.spage=154&rft.epage=158&rft.pages=154-158&rft.issn=1660-3796&rft_id=info:doi/10.1159/000526349&rft_dat=%3Cproquest%3E2802423744%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2802423744&rft_id=info:pmid/&rfr_iscdi=true |